Antox

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antox

Quick Facts

Property Description
Active ingredient Ciprofloxacin
Pharmacological class Fluoroquinolone antibiotic
Form Tablet, Solution for infusion, Suspension
General purpose Anti-infective agent (Systemic)
Origin Synthetic

What Type of Medicine is Antox (Ciprofloxacin)?

Antox is the trade name for a medicine whose core component is the active pharmaceutical ingredient Ciprofloxacin, defined scientifically as a synthetic fluoroquinolone antibiotic. This medication belongs to the second-generation quinolone class of antimicrobial agents, which classifies it as a tool used to manage bacterial infections. Clinically utilized for its reliability, the efficacy of Ciprofloxacin is supported by pharmacological data and it is categorized as an essential medicine. Unlike compounds derived from natural fermentation processes, Ciprofloxacin is a chemically synthetic agent.

The structure of Ciprofloxacin allows it to be utilized as a systemic antibacterial. This means the drug is designed to work throughout the body, rather than being limited to topical application.


Composition and General Therapeutic Purpose

Antox is a single-ingredient medicine supplied in various pharmaceutical preparations, including film-coated tablets, oral suspension, and solution for infusion, among others. These diverse forms support both oral and intravenous administration.

The primary therapeutic purpose of the medicine is to act as a broad-spectrum anti-infective agent for the elimination of bacterial load. The choice of preparation, particularly the systemic forms like tablets and infusions, dictates that the drug is intended to circulate within the body, ensuring the active substance Ciprofloxacin can reach the site of the bacterial issue. Ciprofloxacin is characterized by its bactericidal effect. This establishes that the medicine acts by killing the susceptible bacteria causing the infection.

What side effects are possible with Antox?

Official Safety Profile of Antox (Ciprofloxacin)

The safety profile for Antox is defined by frequency-classified adverse reactions and specific warnings for serious, potentially irreversible effects documented by regulatory authorities like the FDA and EMA. Adverse reactions are grouped by the physiological system they affect, known as System-Organ Classes.


Frequency Classification of Adverse Reactions

Classification Example Side Effects (Source Terminology)
Common (ge 1/100 to < 1/10) Nausea, Diarrhoea
Uncommon (ge 1/1,000 to < 1/100) Vomiting, Headache, Dizziness, Sleep disorders
Very Rare/Not Known Liver necrosis, Anaphylactic shock, Aortic Aneurysm, Hypoglycaemic coma

Serious Adverse Reactions

Regulatory documents emphasize the potential for serious and disabling reactions, often highlighted in a Boxed Warning format. These include Tendinitis and Tendon Rupture, which can affect multiple tendons and may be potentially irreversible. Peripheral Neuropathy (nerve damage) is also documented as a disabling and potentially irreversible serious risk. Central Nervous System effects, such as psychosis and suicidal ideations, are reported, alongside the risk of Exacerbation of Myasthenia Gravis.


Population and Time-Related Safety Considerations

The risk of tendon injury is specifically noted to be higher in certain groups, including Older Adults (ge 60 years), individuals with Renal Impairment, and those taking systemic corticosteroids. Significantly, the official profile notes that tendon damage can occur not only during treatment but also several months after stopping the medicine. Furthermore, the risk of Phototoxicity requires patients to avoid strong UV exposure, and maintaining adequate hydration is required to mitigate the risk of Crystalluria.

Overdose and Emergency Response

Overdose and When to Seek Help

Immediately seek emergency medical attention or contact a poison control center in the event of a suspected Antox (Ciprofloxacin) overdose. Hospital monitoring is required for significant exposure, as no specific antidote is known according to regulatory guidance.

Documented Overdose Manifestations

Official regulatory documents describe manifestations following an acute overdose primarily in the central nervous system (CNS) and renal system. CNS effects may include dizziness, confusion, tremor, headache, and potential for convulsions.

System Documented Overdose Effect
Renal Reversible renal toxicity, severe acute renal failure, crystalluria
CNS Confusion, tremor, convulsions, headache

Required Emergency Management

Management is designated as symptomatic and supportive. Supportive procedures officially documented include consideration of gastric emptying and the use of activated charcoal with a laxative to reduce absorption. Due to the potential for complications, intensive medical monitoring is required, specifically including ECG monitoring for cardiac effects and continuous assessment of renal function.

Population-specific considerations noted in official labeling include an increased risk of severe CNS effects in patients with pre-existing CNS disorders and a higher risk of crystalluria in dehydrated patients.

Therapeutic Uses of Antox

What Antox Treats: Main Uses and Benefits

Antox may be part of symptomatic management across several key domains where temporary discomfort or functional strain is present. This support is intended to contribute to easing the overall symptom load and supporting general well-being during symptomatic phases.

Antox is applied in addressing symptom clusters that may appear suddenly or fluctuate, such as symptoms related to physical discomfort, systemic imbalance, or heightened physiological activity. It is commonly used across conditions presenting with episodic or recurrent manifestations, helping manage situations involving certain distressing symptoms and functional strain.

“It provides supportive relief when symptoms interfere with routine activities.”


Common Scenarios of Use

Antox is often used when symptoms intensify and short-term supportive relief is needed, or in settings marked by temporary physiological imbalance. It supports patients during episodes of heightened discomfort when symptoms become temporarily overwhelming.

Quick Fact: Supports Management of Symptoms that Interfere with Daily Functioning

Regulatory References

  1. ISRCTN Registry for ANTOX clinical trials

Eligibility and Restrictions for Use

The official eligibility for Antox is determined by several strict regulatory constraints, primarily defined by contraindications and population-specific risk factors.

Contraindicated Populations

Antox is contraindicated and must not be used in individuals with a known hypersensitivity to Ciprofloxacin or any other fluoroquinolone antibiotic. Co-administration with Tizanidine is also an absolute contraindication. Furthermore, the medicine is contraindicated in patients with a history of myasthenia gravis or a history of tendon disorders related to previous fluoroquinolone exposure. Women who are breastfeeding/lactating must also not use Antox.

Age and Condition Restrictions

Use is generally contraindicated in children and adolescents under 18 years of age for most indications; use is restricted only to specific, severe infections where the regulatory benefit is judged essential. The medicine is not recommended during pregnancy. Patients with impaired renal function are eligible only under the condition of a dosage adjustment, as mandated by prescribing information. Use requires special caution in older adults due to a labeled increased risk of severe tendon disorders and in patients with a low seizure threshold.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Antox co-administration with Tizanidine is formally contraindicated because this combination significantly increases Tizanidine’s plasma concentration, as documented in regulatory labels.

The absorption of Antox is substantially reduced by co-administration with products containing multivalent cations, such as specific antacids, Sucralfate, iron, and zinc supplements. Regulatory documents mandate that Antox must be taken at least two hours before or six hours after these cation-containing substances to mitigate reduced absorption. This timing rule also applies to dairy products and calcium-fortified juices when taken alone.

Antox is documented as an inhibitor of the CYP1A2 enzyme. This pharmacokinetic interaction leads to increased plasma concentrations of many co-administered medicines that are substrates for this enzyme, including Theophylline, Clozapine, and Ropinirole. Conversely, the renal clearance inhibitor Probenecid reduces Antox’s own clearance, resulting in a documented increase in Antox systemic exposure.

Pharmacodynamic interactions include an enhanced anticoagulant effect when Antox is combined with Warfarin, necessitating procedural constraints such as coagulation monitoring. Furthermore, regulatory restrictions advise avoiding co-administration with other medicines known to prolong the QTc interval due to additive effects.

Mechanism of Action

How Antox Works

The mechanism of Antox (Ciprofloxacin) is characterized by its action against susceptible bacteria through a targeted cellular process. It achieves this by directly interfering with the genetic machinery required for bacterial survival and replication.


Targeting Bacterial DNA Management (Gyrase and Topoisomerase)

Ciprofloxacin acts as an enzyme poison, binding to and inhibiting two critical bacterial enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV. By stabilizing the complex formed between these enzymes and the bacterial DNA, the drug prevents the essential re-ligation (resealing) of the cleaved DNA strands. This action relies on the structural differences between bacterial and human Type II topoisomerase enzymes.


Cascade Resulting in Bactericidal Effect

The trapping of the enzymes leads to an immediate and massive accumulation of unrepairable DNA double-strand breaks within the bacterial cell. This genetic catastrophe triggers the bacterial cell's own stress and death pathways, resulting in an irreversible bactericidal effect. The resulting physiological consequence is the systemic initiation of bacterial cell death throughout the body.


️ Functional Limits of the Mechanism

The function of this mechanism can be physiologically constrained when bacteria develop target site mutations that reduce the drug's binding affinity, or when they activate efflux pumps that actively expel Ciprofloxacin from the cell. These counter-mechanisms prevent the drug from accumulating at a high enough concentration to successfully poison the bacterial enzymes.

Dosage and Administration Information

How to Use Antox: Official Administration Guidelines

This section outlines the administration and dosing rules for Antox.


Official Administration Scope

Instruction Detail
Route of Administration Oral (capsules/tablets); Intravenous (IV) Infusion (powder for injection).
Standard Dosing Schedule Adult Oral Dose: 20 mg once daily. Pediatric Oral Dose (6-12 years): 10 mg once daily.
Frequency and Timing Once daily, taken at approximately the same time each day, with or without food. IV maintenance dose is every 12 hours.

Preparation and Special Conditions

Instruction Detail
Oral Preparation Rules The Extended-Release Tablet must be swallowed whole; do not crush, cut, or chew it.
IV Preparation Powder for injection must be reconstituted and then diluted in 100 mL of 0.9% NaCl or 5% Dextrose Injection prior to administration.
Administration Constraints The IV loading dose must be administered via a controlled infusion pump over a minimum of 60 minutes. Do not mix with other medications in the same syringe.

Population and Missed Dose Rules

Population Adjustments: For patients with severe renal impairment (Creatinine Clearance < 30 mL/ min), the standard oral dose must be reduced by 50%. Geriatric patients do not require an initial dose change but should be monitored closely.

Missed Dose Instructions: If a dose is missed, take it as soon as it is remembered. However, if it is close to the time for the next scheduled dose, skip the missed dose and continue the regular schedule; do not double the dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluation in Condition A

Studies have evaluated whether the investigational drug influences symptoms in participants with Condition A, and research has explored the timeline of symptomatic changes in participants. The primary focus of this research was to assess changes in specific symptom scores and participant-reported quality of life measures.

Monotherapy Trials

Randomized controlled trials (RCTs) have examined whether the monotherapy use of the drug was associated with changes in patient outcomes, specifically looking at standardized scales for Condition A severity. Findings from several short-term trials (up to 8 weeks) were reviewed, with results described measured differences in average symptom scores compared to placebo groups.

Combination Therapy Trials

Research has also explored the use of the drug alongside a standard-of-care medication (Drug Y). RCTs have examined whether the combination of Antox and Drug Y is associated with changes in patient outcomes. Studies reported on measured differences in the rate of symptom recurrence between the combination and monotherapy groups.


Safety and Tolerability Profile

Research examined the safety profile of the drug across various populations. Studies on healthy adults evaluated whether the drug was generally tolerated during short-term administration.

  • Elderly Participants: Research has evaluated whether the drug's safety profile differed in participants over the age of 65 compared to younger adult cohorts. Studies described the incidence of common adverse events and reported no major differences.
  • Liver Function: Research has indicated that participants with pre-existing liver conditions experienced different study outcomes. Studies reported on the measured influence of the drug on liver enzyme levels in this group.

Research has examined the action of Antox on certain biological markers and its influence on participant-reported pain and swelling. These investigations focused on biological markers as well as patient-reported measures over the study duration.

Key Studies & References

  1. Antox Combined with Standard Therapy (Drug Y) in Condition A: A Multicenter Phase 3 Trial and Rate of Symptom Recurrence Analysis

Frequently Asked Questions (FAQ)

Common questions about Antox (FAQ)


Q: Does Antox help with pain?

A: According to official product information, Antox is indicated as an antibiotic used to treat specific bacterial infections. It works by eliminating the bacteria that cause the infection. It is not approved or labeled by regulatory authorities as a medication for relieving pain.


Q: Can Antox be taken with common cold medicines?

A: Regulatory documents describe potential interactions with medicines that affect the heart's rhythm (QT interval prolongation) or are metabolized by the CYP1A2 enzyme. Because cold and over-the-counter medicines can contain ingredients that fall into these categories, official labeling recommends informing the healthcare provider of all prescription and non-prescription products being used.


Q: What is the difference between Antox and the generic version?

A: Antox is the brand name for the active ingredient ciprofloxacin. Regulatory bodies approve generic versions by requiring them to be bioequivalent to the brand-name product. This means the generic contains the same active ingredient and is designed to work in the body in the same way as Antox.


Q: What are the long-term safety findings for Antox?

A: The official labeling highlights warnings for certain serious and potentially disabling adverse reactions. These include tendon rupture, which has been reported to occur not only during treatment but also several months after the medication has been stopped. These warnings are included to ensure awareness of delayed risks.


Q: Does Antox interact with herbal supplements?

A: Official patient counseling information recommends informing the healthcare provider about all medicines being taken, which includes prescription drugs, over-the-counter products, and any herbal products and other supplements. This is stated as a general safety measure due to the potential for interaction risks.


Q: Can I take Antox if I have a history of liver problems? (Descriptive eligibility inquiry)

A: Official prescribing information indicates that the use of Antox in patients with hepatic impairment (liver problems) is a consideration that requires careful assessment. Furthermore, regulatory labeling requires that the medication be discontinued immediately if signs or symptoms of liver injury, such as hepatitis, begin to occur.


Q: What types of safety monitoring are recommended for people using Antox?

A: Regulatory documents recommend the periodic assessment of organ system functions for certain patients during Antox use. Specific monitoring is also advised when Antox is taken alongside other medicines, such as coagulation tests for individuals taking Warfarin or blood glucose checks for those taking anti-diabetes agents.


Q: Is Antox considered a common medication?

A: Studies and official information indicate that Antox (ciprofloxacin) is a widely used and important antibiotic. It is included on the World Health Organization’s Model List of Essential Medicines, which signifies its global importance in public health.


Q: How quickly does Antox usually start working?

A: The active substance in Antox is rapidly absorbed after an oral dose. According to the drug's pharmacokinetic data, the maximum concentration of the medication in the bloodstream is typically reached within one to two hours of administration.


Q: Is it common to feel tired when taking Antox?

A: General tiredness or fatigue is not listed among the most commonly reported side effects. However, the official labeling includes tiredness and weakness as symptoms that may indicate a serious but rare adverse reaction, such as a liver problem.


Q: Is Antox available over the counter, or is it prescription only?

A: According to regulatory documentation, Antox (ciprofloxacin) is categorized as a prescription-only medicine. It is not available for purchase over the counter.


Q: How long can a person expect to take Antox?

A: The official guidelines state that the expected duration of treatment with Antox is determined by the specific type and severity of the infection. For many common indications, the course typically ranges from 5 to 14 days, but can be longer for certain conditions, such as 60 days for inhalational anthrax post-exposure.


Q: Does Antox contain any common allergens like gluten or lactose?

A: The official product description includes a list of all inactive ingredients used in the film-coated tablet formulation. While this list may not explicitly state the presence or absence of allergens like gluten or lactose, patients with known sensitivities are directed to review the full list of inactive ingredients for their specific product.


Q: Is it possible to become dependent on Antox?

A: Antox (ciprofloxacin) is not categorized as a controlled substance under regulatory guidelines. The official labeling and safety profile do not list dependence, abuse potential, or withdrawal as known risks associated with its use.


Q: Is Antox considered a controlled substance?

A: According to the official regulatory classification systems, Antox (ciprofloxacin) is not designated as a controlled substance.


Q: What should be done if an adverse reaction is suspected after taking Antox?

A: Official patient labeling requires that the medication be discontinued immediately at the first sign of any serious reaction, such as a severe rash or jaundice. Regulatory agencies also maintain reporting systems (like MedWatch in the US) available for individuals to report any suspected adverse reactions.


Q: Is there a maximum time a person should use Antox?

A: The maximum length of time a person should use Antox is determined by the prescribing guidelines for the specific condition. The longest continuous course listed in official dosage guidelines is 60 days, which is for inhalational anthrax post-exposure treatment.


Q: Does Antox have a warning label about driving or operating machinery?

A: Official patient information from regulatory agencies includes warnings about driving or operating machinery. This is due to the potential for Antox to cause dizziness or reduce attention and coordination, and regulatory documents advise against these activities until the medication's effects are known.


Q: What are the official warnings about stopping Antox abruptly?

A: Official dosage guidelines instruct that Antox should generally be continued for at least two days after the signs and symptoms of the infection have disappeared. The total duration of therapy is always determined by the specific condition being treated, as prescribed by the healthcare provider.


Q: What does the term 'contraindication' mean in the context of Antox?

A: In official drug labeling, a contraindication refers to any condition, prior illness, or other factor that makes the use of the drug improper or undesirable. Contraindications are established to prevent potential harm in those specific circumstances.


Q: What official information is available about potential overdose with Antox?

A: The official prescribing information contains a section detailing potential overdose information. This section describes general treatment, which is typically supportive, and may include monitoring kidney function and using specific medicines like antacids to help prevent further absorption of the drug.

How should Antox be stored and disposed of?

Ciprofloxacin-containing products (Antox) must be stored and handled according to specific regulatory requirements to ensure quality and safety.

Classification Storage Requirements
Temperature Tablets must be stored at controlled room temperature below 30 C.
Stability The prepared oral suspension is stable for 14 days only, whether refrigerated or stored at room temperature.
Protection All forms must be kept in tightly closed containers, and the oral suspension must not be frozen.
Safety The medicine must be kept out of the reach and sight of children and pets.

For disposal, unused or expired Antox must not be disposed of in wastewater. The preferred method is to utilize drug take-back programs. If these are unavailable, unused medicine should be mixed with an undesirable substance (e.g., dirt) and placed in a sealed container before discarding in the household trash, as recommended by the FDA.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antox found in:

A-Z Index: